| 发明名称 | Drug having regulatory cell ligand contained in liposome | ||
| 摘要 | A liposome containing a regulatory cell ligand such as α-galactosyl ceramide or β-galactosyl ceramide is employed as the active ingredient of a drug for preventing or treating immune diseases etc. | ||
| 申请公布号 | US8920774(B2) | 申请公布日期 | 2014.12.30 |
| 申请号 | US201012687728 | 申请日期 | 2010.01.14 |
| 申请人 | Riken | 发明人 | Ishii Yasuyuki;Nozawa Risa;Taniguchi Masaru |
| 分类号 | A61K39/00;A61K45/00;A61K51/00;A61K31/4745;A61K9/127;A61K31/7028;A61K31/7088 | 主分类号 | A61K39/00 |
| 代理机构 | Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P. | 代理人 | Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P. |
| 主权项 | 1. A method of preventing or treating graft versus host disease (GVHD) upon transplantation in a patient, comprising administering a liposome containing KRN7000 to the patient receiving an allogeneic transplant. | ||
| 地址 | Wako-shi JP | ||